These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

986 related articles for article (PubMed ID: 27338520)

  • 1. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
    Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
    J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.
    Munroe ME; Lu R; Zhao YD; Fife DA; Robertson JM; Guthridge JM; Niewold TB; Tsokos GC; Keith MP; Harley JB; James JA
    Ann Rheum Dis; 2016 Nov; 75(11):2014-2021. PubMed ID: 27088255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
    Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
    Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways of impending disease flare in African-American systemic lupus erythematosus patients.
    Munroe ME; Vista ES; Merrill JT; Guthridge JM; Roberts VC; James JA
    J Autoimmun; 2017 Mar; 78():70-78. PubMed ID: 28162788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus.
    Eriksson C; Rantapää-Dahlqvist S
    Lupus; 2014 Jun; 23(7):691-6. PubMed ID: 24531079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.
    Munroe ME; Young KA; Kamen DL; Guthridge JM; Niewold TB; Costenbader KH; Weisman MH; Ishimori ML; Wallace DJ; Gilkeson GS; Karp DR; Harley JB; Norris JM; James JA
    Arthritis Rheumatol; 2017 Mar; 69(3):630-642. PubMed ID: 27863174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals.
    Munroe ME; Young KA; Guthridge JM; Kamen DL; Gilkeson GS; Weisman MH; Ishimori ML; Wallace DJ; Karp DR; Harley JB; Norris JM; James JA
    Front Immunol; 2022; 13():866181. PubMed ID: 35720322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
    Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
    Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
    Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
    Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
    Front Immunol; 2020; 11():1047. PubMed ID: 32625200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
    Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z
    Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Boghdadi G; Elewa EA
    Rheumatol Int; 2014 Sep; 34(9):1217-23. PubMed ID: 24748505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
    Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
    Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.
    Munroe ME; Vista ES; Guthridge JM; Thompson LF; Merrill JT; James JA
    Arthritis Rheumatol; 2014 Jul; 66(7):1888-99. PubMed ID: 24578190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
    Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
    Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.
    Aberle T; Bourn RL; Munroe ME; Chen H; Roberts VC; Guthridge JM; Bean K; Robertson JM; Sivils KL; Rasmussen A; Liles M; Merrill JT; Harley JB; Olsen NJ; Karp DR; James JA
    Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1780-1788. PubMed ID: 28118528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.
    Young KA; Terrell DR; Guthridge JM; Kamen DL; Gilkeson GS; Karp DR; Ishimori ML; Weisman MH; Holers VM; Harley JB; Norris JM; James JA
    Lupus; 2014 Apr; 23(4):360-9. PubMed ID: 24449338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine Profiles in Autoantibody Defined Subgroups of Systemic Lupus Erythematosus.
    Torell F; Eketjäll S; Idborg H; Jakobsson PJ; Gunnarsson I; Svenungsson E; Trygg J
    J Proteome Res; 2019 Mar; 18(3):1208-1217. PubMed ID: 30742448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.